Indications

Inflammatory Diseases

  • 50+ clinical sites in Poland, Bulgaria, Romania, Germany
  • 50+ investigators in rheumatology

Common cold

  • phase III trials in 1200 patients
  • pivotal trials for Grippostad® products

Rheumatoid Arthritis

  • pharmacokinetic trial in 50 patients